Guo Qiaoyan, Liu Lihua, Nie Ping, Luo Ping
Department of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China.
Exp Ther Med. 2020 Dec;20(6):140. doi: 10.3892/etm.2020.9269. Epub 2020 Oct 5.
Collagen type III is commonly detected in the renal interstitium and vasculature; however, it is absent in healthy glomeruli. Deposition of collagen type III in the glomerular mesangium and capillary basement membranes may arise in two rare diseases, namely collagen type III glomerulopathy (CG) and nail patella syndrome. CG is a rare glomerular disease with no specific treatment, although supportive measures for control of hypertension and edema may help to relieve symptoms. With progression to end-stage renal disease, patients with CG may come to require dialysis and/or renal transplantation. The present study reported on a 59-year-old male who was diagnosed with CG nephrotic syndrome by immunohistochemical and electron microscopic examination of biopsy material. To the best of our knowledge, this is the first case reported in northeastern China. The angiotensin II blocker telmisartan was successfully used to alleviate renal symptoms and a literature review was performed. The present case supports the use of telmisartan as a first choice of treatment for CG.
III型胶原通常在肾间质和血管系统中被检测到;然而,在健康的肾小球中不存在。III型胶原在肾小球系膜和毛细血管基底膜中的沉积可能出现在两种罕见疾病中,即III型胶原肾小球病(CG)和指甲髌骨综合征。CG是一种罕见的肾小球疾病,没有特异性治疗方法,尽管控制高血压和水肿的支持性措施可能有助于缓解症状。随着疾病进展到终末期肾病,CG患者可能需要透析和/或肾移植。本研究报告了一名59岁男性,通过对活检材料进行免疫组织化学和电子显微镜检查诊断为CG肾病综合征。据我们所知,这是中国东北地区报道的首例病例。血管紧张素II受体阻滞剂替米沙坦成功用于缓解肾脏症状,并进行了文献综述。本病例支持将替米沙坦作为CG治疗的首选药物。